Preferential Cochleotoxicity of Cisplatin.

Area of Science:

• Ototoxicity research
• Inner ear physiology
• Pharmacology

Background:

• Cisplatin chemotherapy is known to cause ototoxicity, primarily affecting the cochlea.
• Vestibular dysfunction is less consistently reported, suggesting differential susceptibility within the inner ear.
• Inner ear hair cells may possess inherent characteristics influencing cisplatin sensitivity.

Purpose of the Study:

• To explain the preferential cochleotoxicity of cisplatin.
• To explore the role of inner ear anatomy and physiology in cisplatin's ototoxic effects.
• To identify potential targets for otoprotective strategies.

Main Methods:

• Review of existing literature on cisplatin ototoxicity.
• Analysis of inner ear anatomy and physiology.
• Hypothesizing mechanisms of differential drug uptake and hair cell susceptibility.

Main Results:

• Cisplatin-induced ototoxicity predominantly impacts the cochlea over the vestibule.
• Differences in blood-labyrinth barrier drug trafficking or hair cell uptake may exist between cochlear and vestibular compartments.
• The endocochlear potential, driven by the stria vascularis, might enhance cisplatin entry into cochlear hair cells.

Conclusions:

• The stria vascularis and endocochlear potential may contribute to preferential cochlear damage.
• Understanding these mechanisms could lead to otoprotective interventions against cisplatin ototoxicity.
• Further research into the stria vascularis is crucial for developing such therapies.